Aytu BioPharma Completes $15 Million Debt Refinancing
ENGLEWOOD, CO / ACCESSWIRE / January 31, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that it has entered into an agreement with the Avenue more...
Celsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate
Preclinical results d emonstrate safe and efficient immune response with v accine development showing promise of neutralizing activity for a range of variants LAWRENCEVILLE, N.J., Jan. 31, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), more...
Immutep to Present at February Investor Conferences
SYDNEY, AUSTRALIA, Jan. 31, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, announced today that more...
4Front Ventures Corp. Further Strengthens Massachusetts Footprint, Closes Accretive Acquisition of New England Cannabis Corporation
4Front Ventures Corp. Further Strengthens Massachusetts Footprint, Closes Accretive Acquisition of New England Cannabis Corporation PR Newswire Significantly expands strategic position and broadens market penetration in important limited-license state of Massachusetts Acquisition expected to be more...
Austral Gold Announces Filing of Q4 2021 Quarterly Activity Report
Sydney, Australia–(Newsfile Corp. – January 31, 2022) – Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (the “Company”) is pleased to announce that it has filed its Q4 2021 Quarterly Activity Report. The complete Report is more...
Amarc Appoints Dr. Roy Greig, P.Geo, As Its New VP-Exploration
VANCOUVER, BC / ACCESSWIRE / January 31, 2022 / Amarc Resources Ltd. (“Amarc” or the “Company”) (TSXV:AHR)(OTCQB:AXREF) is pleased to announce the appointment of Dr. Roy Greig, PhD, P.Geo., of C.J. Greig & Associates Ltd. more...
BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS(TM) for the Treatment of OCD
Palmetto GBA Covers Medicare Patients in Seven States BURLINGTON, Mass. and JERUSALEM, Jan. 31, 2022 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation more...
Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services
Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the first half of 2023 Reaffirms ANTHIM as an important medical countermeasure in the U.S. government’s more...
SIBANNAC, INC. TO BEGIN MANUFACTURING INVENTORY FOR ITS NEW FLAGSHIP BRAND
Scottsdale, Arizona, Jan. 31, 2022 (GLOBE NEWSWIRE) — Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: The Company is continuing its evolution into a multi-faceted and vertically integrated next-generation wellness brand. more...
Aravive Announces First Patient Dosed in Phase 2 Study of Batiraxcept in Clear Cell Renal Cell Carcinoma
Preliminary top line data anticipated throughout 2022 HOUSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that the Company more...